Articles From: BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2013 to Lieff Cabraser Announces Class Action Litigation Against Lumber Liquidators Holdings, Inc. - LL


2013/12/12
ELMWOOD PARK, N.J., Dec.
Sign-up for BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2013 investment picks
WASHINGTON (MarketWatch) -- Social-networking firm Facebook (FB) will join the S&P 500, replacing Teradyne (TER), S&P Dow Jones Indices said Wednesday.
Sign-up for UPDATE: Facebook set to join S&P 500 investment picks
IIROC Trade Resumption - COP Canada NewsWire TORONTO , Dec.
Sign-up for IIROC Trade Resumption - COP investment picks
2013/12/12
SAN FRANCISCO (MarketWatch) -- General Motors Co.
Sign-up for GM to sell its 7% stake in Peugeot investment picks
2013/12/12
NEW YORK (MarketWatch) - Southwest Airlines Co (LUV) is the biggest gainer on the S&P 500, up 3.7% after analysts at Bank of America upgraded the stock to buy from neutral with the price target of $23. From their research note: "Domestic small-business bookings are outperforming and the domestic supply outlook is relatively tighter than international.
Sign-up for UPDATE: Southwest Airlines shares jump on upgrade investment picks
Ford Motor Co.
Sign-up for Ford to Hire More Than 3,000 Workers investment picks
0547 GMT [Dow Jones] Taiwan shares rise 0.9% to a year-high close of 8444.62, following signs of improvement in the U.S. economy and a rally on the Wall Street, says Masterlink Investment Advisory assistant vice president, Tom Tang.
Sign-up for Taiwan Stocks End 0.9% Higher; 8400-8480 Band Tipped Tuesday investment picks
2013/12/11
By Rex Crum, MarketWatch SAN FRANCISCO (MarketWatch) -- Tech stocks followed the broader market south Wednesday, with Cisco Systems Inc. among the decliners after Citigroup started its coverage of the company with a sell recommendation and a list of concerns about the networking-equipment giant.
Sign-up for UPDATE: Cisco among losses in broad tech slump investment picks
2013/12/11
Vista Gold Corp.
Sign-up for Vista Gold Corp. Announces An Agreement To Convert Its Interest In The Awak Mas Gold Project Into A Royalty investment picks
2013/12/12
CHICAGO , Dec.
Sign-up for Save up to 20 Percent Off at Renaissance Schaumburg Convention Center Hotel investment picks
2013/12/12
AMSTERDAM and SAN FRANCISCO , Dec.
Sign-up for New AVG AntiVirus for Mac offers Triple Protection For OS X investment picks
2013/12/11
LONDON , December 11, 2013 /PRNewswire/ -- Royal Dutch Shell plc (NYSE: RDS.A) (NYSE: RDS.B) announces that on 11 December, 2013 it purchased for cancellation 295,023 "B" Shares at a price of 2172.99 pence per share.
Sign-up for Royal Dutch Shell plc: Buyback of Own Shares investment picks
2013/12/7
Gilead Sciences, Inc. (Nasdaq: GILD) today announced interim results from a single-arm, open-label Phase 2 study evaluating GS-9973, an investigational oral inhibitor of spleen tyrosine kinase (Syk), for the treatment of patients with relapsed or refractory hematologic malignancies.
Sign-up for Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia investment picks
2013/12/7
UnitedHealthcare and Mississippi 4-H youth hosted a Family Fun and Fitness Day for Jackson-area families to promote healthy eating and exercise at the Mississippi Basketball & Athletics facility.
Sign-up for Mississippi 4-H Youth and UnitedHealthcare Host Family Fun and Fitness Day to Promote Healthy Lifestyles investment picks
2013/12/7
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Severe winter weather across the U.S. has been blamed for nearly a dozen deaths, more than a thousand canceled flights, and delayed freight deliveries by major shipping companies and online retailers during the busy holiday season.
Sign-up for UPDATE: Killer winter storm disrupts travel, freight investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Severe winter weather across the central U.S. disrupted air travel and caused FedEx Corp.
Sign-up for Wintry weather disrupts FedEx, UPS service investment picks
-- Webcast to be held Monday, December 9th at 9:00 a.m. EST --
Sign-up for Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes investment picks
2013/12/7
NORTHBROOK, Ill.
Sign-up for Allstate Offers Claims Tips After Severe Winter Weather investment picks
UPS ® , a global logistics provider and leading advocate for global trade, welcomes today’s news of an agreement struck at the World Trade Organization to facilitate global commerce and support growth in developing countries.
Sign-up for UPS Applauds Landmark WTO Trade Facilitation Agreement investment picks
RICHMOND, Va.
Sign-up for Dominion Virginia Power is Prepared For Approaching Ice Storm investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced updated Phase 1 data from an ongoing study of IPI-145, its oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with relapsed/refractory indolent non-Hodgkin lymphoma (iNHL), a potentially fatal hematologic malignancy (blood cancer). Data from the study showed that IPI-145 was clinically active, with an overall response rate of 73 percent, including three complete responses, among patients receiving IPI-145 dosed at ≤ 25 mg twice daily (BID). Data also showed that 53 percent of patients remained progression free for over one year.
Sign-up for Infinity Reports Updated Phase 1 Data of IPI-145 in Indolent Non-Hodgkin Lymphoma at ASH Annual Meeting investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced new preclinical data showing the activity of IPI-145, its oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in models of diffuse large B-cell lymphoma (DLBCL) and T-cell acute lymphoblastic leukemia (T-ALL), two difficult-to-treat hematologic malignancies (blood cancers) for which limited treatment options are available.
Sign-up for Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B-Cell Lymphoma and T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential of IPI-145 in Blood Cancers investment picks
http://media.marketwire.com/attachments/201211/99925_41732_threshold.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1074506&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Threshold Pharmaceuticals Reports TH-302 Data at the 55th Annual Meeting of the American Society of Hematology (ASH) investment picks
2013/12/7
Seattle Genetics, Inc. (Nasdaq: SGEN) today presented interim phase 1 clinical data from SGN-CD19A, an antibody-drug conjugate (ADC) in development for the treatment of B-cell malignancies, including acute lymphoblastic leukemia (ALL), at the 55 th American Society of Hematology (ASH) Annual Meeting and Exposition taking place in New Orleans, Louisiana, December 7-10, 2013.
Sign-up for Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate (ADC) SGN-CD19A at ASH 2013 investment picks
QEP Resources, Inc. (NYSE: QEP, “QEP” or the “Company”) today announced that members of the Company’s senior management will participate in the upcoming Wells Fargo 12 th Annual Pipeline, MLP and Energy Symposium on Wednesday, December 11, 2013 at 10:20 a.m. EST (8:20 a.m. MST) and the Capital One Securities 8 th Annual Energy Conference on Wednesday, December 11, 2013 at 3:00 p.m. CST (2:00 p.m. MST). Links to the webcasts and copies of the presentations will be available at www.qepres.com on the morning of Wednesday, December 11 th .
Sign-up for QEP Resources Announces Participation in Upcoming Investor Conferences investment picks
2013/12/7
San Antonio, TX , Dec.
Sign-up for Biglari Holdings Inc. News Release investment picks
2013/12/7
The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of purchasers of the securities of Lumber Liquidators Holdings, Inc. (“Lumber Liquidators” or the “Company”) (NYSE:LL) between February 22, 2012 and November 21, 2013, inclusive (the “Class Period”). If you purchased the securities of Lumber Liquidators during the Class Period, you may move the Court for appointment as lead plaintiff by no later than January 27, 2014.
Sign-up for Lieff Cabraser Announces Class Action Litigation Against Lumber Liquidators Holdings, Inc. - LL investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2013 to Lieff Cabraser Announces Class Action Litigation Against Lumber Liquidators Holdings, Inc. - LL
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity